Ilse Verstraeten SRL
Ilse Verstraeten reported total assets of 178,548 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Ilse Verstraeten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +175 % Total assets +108 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ilse Verstraeten's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 48,049 € | ||||
| Equity | 174,721 € | ||||
| Cash | 77,894 € | ||||
| EBITDA | 73,312 € | ||||
| Total assets | 178,548 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jun 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jun 2022
Ilse Verstraeten's financial analysis
- Solvency97.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ilse Verstraeten
Ilse Verstraeten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0834.826.540
- VAT number
- BE0834826540
- Peppol
- Registered · 0208:0834826540 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 2011
- Registered office
- 3800 Sint-Truiden
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ilse Verstraeten (SRL) has been based in Sint-Truiden since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 48,049 € and equity of 174,721 €; its revenue is not published. Its solvency stands at 97.9%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ilse Verstraeten
Companies in the same business, of comparable size and area, outside its group.
- Abelaphar Retail sale of pharmaceutical products Bornem · balance sheet 178,162 €
- Pharmacie WAGMANS-CREMA Retail sale of pharmaceutical products Dalhem · balance sheet 167,379 €
- Apotheek d'Hondt Pascal Retail sale of pharmaceutical products Lokeren · balance sheet 177,633 €
- Hilde Braeken Retail sale of pharmaceutical products Hasselt · balance sheet 180,493 €
- Emilie Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,476 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Naturotheek Lindenbos Retail sale of other food Aartselaar · balance sheet 170,770 €
Frequently asked questions about Ilse Verstraeten
What is the revenue of Ilse Verstraeten?
Ilse Verstraeten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ilse Verstraeten?
In Belgium, the VAT number is the company number prefixed with BE: BE0834826540 for Ilse Verstraeten, if the company is VAT-registered. Its company number (CBE) is 0834.826.540.
Where is the registered office of Ilse Verstraeten?
According to the CBE register, the registered office of Ilse Verstraeten is in 3800 Sint-Truiden.
What is the equity of Ilse Verstraeten?
At the close of the 2025 financial year, the equity of Ilse Verstraeten amounts to 174,721 €, a solvency of 97.9% of total assets.
Who manages Ilse Verstraeten?
The register lists 2 active mandates at Ilse Verstraeten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ilse Verstraeten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →